IBA rises on improved proton therapy profitability
BUZZ-IBA rises on improved proton therapy profitability ** Shares in Belgian radiation therapy company IBA IBAB.BR rise 3.6% after what analysts see as good H1 results driven by its main proton therapy biz
** IBA's REBIT rises 66% y/y to €17.6 million ($20.51 million) driven by rapid improvement in proton therapy profitability
** IBA sold 5 proton therapy rooms in H1
** KBC notes a high net debt at €81 million but says the group is "on track" as it reiterates its guidance
** Including today's rise, the stock has gained 29.4% year-to-date
($1 = 0.8581 euros)
(Reporting by Lucie Barbier in Gdansk)
Recent news on Ion Beam Applications SA
See all newsBrief: IBA Signs Contract With Government Of Assam For India's State-Run Proton Therapy Center
Brief: Iba Signs Contract For Be Efficient Sterilization Solution In Germany
Brief: IBA Says First Patient Treated In C-Flash-01 Conformalflash Clinical Trial
Brief: IBA Selected To Support The US Expansion Of Radiopharmaceutical Producer
Brief: IBA And Telix Strengthen Ties Through Agreement To Distribute ARTMS QIS